These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2842389)

  • 41. Effects of salbutamol and metoprolol on plasma renin activity and plasma potassium of normal subjects and of hypertensive patients.
    Salvetti A; Poli L; Arzilli F; Sassano L; Pedrinelli R; Motolese M
    J Endocrinol Invest; 1978 Jan; 1(1):1-8. PubMed ID: 226572
    [No Abstract]   [Full Text] [Related]  

  • 42. The inhibiton of adrenergically provoked renin release by salbutamol in man.
    Wiggins R; Davies R; Basar I; Slater JD
    Br J Clin Pharmacol; 1978 Mar; 5(3):213-5. PubMed ID: 656264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mechanism of salbutamol-induced hypokalaemia.
    Whyte KF; Addis GJ; Whitesmith R; Reid JL
    Br J Clin Pharmacol; 1987 Jan; 23(1):65-71. PubMed ID: 3545273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men.
    Leitch AG; Clancy LJ; Costello JF; Flenley DC
    Br Med J; 1976 Feb; 1(6006):365-7. PubMed ID: 1247857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of salbutamol on some metabolic and endocrine patterns of diabetic subjects.
    Torella R; Grandillo F; Giugliano D; Improta L; Varricchio M
    Pharmacol Res Commun; 1980 Oct; 12(9):909-19. PubMed ID: 7003602
    [No Abstract]   [Full Text] [Related]  

  • 46. Selective metabolic effects of salbutamol in anesthetized cats.
    Lockwood RH; Sinkasaem P
    Life Sci; 1976 Feb; 18(4):405-9. PubMed ID: 1256244
    [No Abstract]   [Full Text] [Related]  

  • 47. Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol.
    Phillips PJ; Vedig AE; Jones PL; Chapman MG; Collins M; Edwards JB; Smeaton TC; Duncan BM
    Br J Clin Pharmacol; 1980 May; 9(5):483-91. PubMed ID: 6104976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease.
    Stemmer CL; Perez GO; Oster JR
    J Clin Pharmacol; 1987 Aug; 27(8):628-31. PubMed ID: 2821083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic effects of oral salbutamol.
    Taylor MW; Gaddie J; Murchison LE; Palmer KN
    Br Med J; 1976 Jan; 1(6000):22. PubMed ID: 764913
    [No Abstract]   [Full Text] [Related]  

  • 50. Extrapulmonary beta 2-responses to intravenous salbutamol during the menstrual cycle.
    Newnham DM; Wheeldon NM; McFarlane LC; Clark GA; McDevitt DG; Lipworth BJ
    Eur J Clin Pharmacol; 1994; 46(6):511-5. PubMed ID: 7995317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The metabolic effects of inhaled salbutamol.
    Bateman SM; Pidgeon J; Spiro SG; Johnson AJ
    Br J Clin Pharmacol; 1978 Feb; 5(2):127-9. PubMed ID: 339934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucose tolerance following oral salbutamol treatment in late pregnancy.
    Wager J; Lunell NO; Nadal M; Ostman J
    Acta Obstet Gynecol Scand; 1981; 60(3):291-4. PubMed ID: 7023174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of the blood glucose level on the metabolic response of intravenous salbutamol.
    Huupponen R; Pihlajamäki K
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):374-6. PubMed ID: 3525429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic effects of salbutamol infusion during premature labour.
    Thomas DJ; Dove AF; Alberti KG
    Br J Obstet Gynaecol; 1977 Jul; 84(7):497-99. PubMed ID: 911704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypokalemia before induction of anesthesia and prevention by beta 2 adrenoceptor antagonism.
    Kharasch ED; Bowdle TA
    Anesth Analg; 1991 Feb; 72(2):216-20. PubMed ID: 1845926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fenoterol stimulates human erythropoietin production via activation of the renin angiotensin system.
    Freudenthaler SM; Schenck T; Lucht I; Gleiter CH
    Br J Clin Pharmacol; 1999 Oct; 48(4):631-4. PubMed ID: 10583037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man.
    Tantucci C; Santeusanio F; Beschi M; Castellano M; Sorbini C; Grassi V
    J Endocrinol Invest; 1988 Apr; 11(4):279-87. PubMed ID: 2842389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man.
    Sorbini CA; Grassi V; Tantucci C; Corea L; Bentivoglio M; Verdecchia P; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):570-5. PubMed ID: 6150902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
    Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
    Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods.
    Silke B; Hanratty CG; Riddell JG
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):859-67. PubMed ID: 10367588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.